FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...